Applications and prospects of artificial intelligence and digital medicine in pediatric nasal skull base tumors Authors: Xiuping Wu, Jing Wei, Chen Liu, Pengpeng Wang, Wentong Ge, Yang Han Published: 2026 ABSTRACT ABSTRACTPediatric nasal skull base tumors are rare and difficult to diagnose early due to their deep anatomical location and children's limited ability to describe symptoms. When the tumors progress to advanced stages, nonspecific symptoms such as nasal congestion, nosebleeds, and facial swelling are easily confused with sinusitis or trauma, complicating diagnosis and treatment. Moreover, the special tumor anatomical location and the narrow nasal cavity in children increase the risk of tumor involvement with the surrounding structures. Given children's longer life expectancy and higher postoperative quality of life demands, personalized treatment and comprehensive medical management are essential. Advances in artificial intelligence (AI) and digital medicine have played an important role in early diagnosis, multidisciplinary treatment, prognosis assessment, and follow‐up. However, despite the widespread use of emerging AI‐related technologies, their application in pediatric nasal skull base tumors remains limited. This review discusses the potential applications of AI and digital medicine in the whole‐process medical management of these tumors, including diagnosis, treatment, prognosis, and follow‐up, along with current challenges.Keywords: Artificial intelligence, Digital medicine, Nasal skull base tumors, Pediatric, Whole‐process medical management model INTRODUCTION Nasal skull base tumors in children have a low incidence rate and are rarely reported in the literature. 1 , 2 Due to the special anatomical location of the tumor and other factors, nasal skull base tumors in children are characterized by difficulty in early diagnosis, high surgical risk, and poor prognosis of malignant tumors. Artificial intelligence (AI) and digital medicine have rapidly grown over the last decade. AI uses digital and information technology to provide, manage, and improve healthcare services, and is currently being applied in areas such as image recognition, assisting in diagnosis, and treatment planning. 3 Digital medicine involves the use of digital tools to upgrade healthcare data into high‐definition and personalized medical practices. For example, biosensors can be used to track complex physiological systems that digitize data and indicators. Digital medicine can process large amounts of physiological data using algorithms, cloud computing, and AI. Consequently, AI is driving the advancement of digital medicine. 4 With continuous research on machine learning and deep learning, AI‐based digital medicine has been applied to the diagnosis and treatment of a variety of diseases. 5 Currently, AI and digital medicine have made important achievements in the diagnosis, treatment, and prognosis assessment of a variety of cancers, including lung cancer, breast cancer, and upper gastrointestinal tract tumors. 6 , 7 , 8 In addition, the use of AI and digital medicine in otolaryngology has also been reported. 9 To address the difficulties in the diagnosis and treatment of children with nasal skull base tumors, reduce the risk of surgery, increase the survival rate, and improve the quality of life, we summarize and review the prospects for the application of AI and digital medicine in the early diagnosis, treatment, prognostic assessment, and follow‐up of children with nasal skull base tumors to inform the construction of an integrated, coordinated, and continuous model of whole‐process medical management services for pediatric patients. OVERVIEW OF NASAL SKULL BASE TUMORS IN CHILDREN Nasal skull base tumors occur in the region of the nasal cavity, sinuses, and skull base. Their incidence among pediatric tumors is low, and malignant tumors are even rarer, with an incidence rate of approximately 0.036–0.052 per 100 000. 1 , 10 Common benign tumors include congenital masses (gliomas, meningeal brain bulges, and teratomas), hamartomas, nasopharyngeal fibroangiomas, and ossifying fibromas. 11 Malignant tumors often invade the surrounding tissue, grow rapidly, and have a poor prognosis. It has been reported that rhabdomyosarcoma (RMS) is the most common nasal skull base malignant tumor in children, followed by lymphoma, other sarcomas, and olfactory neuroblastoma. 12 , 13 , 14 , 15 Notably, juvenile nasopharyngeal angiofibroma (JNA) is an aggressive fibrovascular benign tumor that occurs in the nasopharynx of adolescent males. 16 Juvenile ossifying fibroma, which occurs at the nasal skull base in children or adolescents, has a similarly aggressive growth pattern and is often accompanied by nasal, orbital, and even internal cranial involvement. The anatomical relationship between the nasal cavity and the base of the skull is complex and close, with multiple channels and foramina connecting the two. In addition, the anatomical region of the skull base is deeply located and is adjacent to and/or functionally related to the eyeball, nasopharynx, eustachian tube, and inner ear in terms of location. The progression of the tumor, on the one hand, compresses the surrounding structures, affecting functions such as vision, breathing, and pronunciation; on the other hand, it involves the intracranium, causing increased intracranial pressure and even metastasis. Similarly, due to the special anatomical location of the tumor, it is not easy to detect in the early stage, while in the later stage, the first symptom is always non‐specific. Common nonspecific manifestations of nasal skull base tumors in children include nasal congestion, epistaxis, olfactory dysfunction, facial swelling, visual impairment, and rhinogenic headaches. These nonspecific manifestations can be easily confused with sinusitis, trauma, and nononcologic lesions. Ossifying fibroma or fibrous dysplasia of the bone involving the cranial base often presents as a nasal dorsum bulge, proptosis, or restricted eye movement. 17 JNA is very aggressive and highly susceptible to peripheral and intracranial dissemination. 18 Pediatric patients often have limitations in growth and development, with poor subjective expression ability and an inability to cooperate with examinations. These factors contribute to the high likelihood of missed diagnosis or misdiagnosis of pediatric nasal skull base tumors. Therefore, it is especially important for pediatric otolaryngologists to remain vigilant and utilize a comprehensive analysis of multiple objective examination results to achieve early diagnosis. Treatment options for pediatric nasal skull base tumors vary depending on the tumor's benign or malignant nature, as well as its grade and stage. With the development of nasal endoscopy technology in recent years, the endoscopic endonasal approach has been widely used in the treatment of nasal skull base lesions in children. 19 Surgical resection remains the primary treatment for benign tumors and offers advantages such as fewer postoperative complications and reduced intraoperative blood loss. Whereas smaller lesions are managed with straightforward excision, larger tumors may require preoperative embolization to reduce surgical bleeding. 20 , 21 For maxillofacial ossifying fibroma, management strategies must be highly individualized, dictated primarily by the tumor's biological behavior and degree of regional invasiveness. 22 , 23 The management of malignant tumors generally involves surgical intervention to alleviate symptoms, supplemented by comprehensive therapies such as radiotherapy, chemotherapy, targeted therapy, and immunotherapy. 24 , 25 Pediatric sinonasal RMS necessitates a multidisciplinary treatment paradigm encompassing chemotherapy, radiotherapy, and surgery. For patients presenting with advanced‐stage disease, chemoradiotherapy is the preferred primary approach. However, if complete tumor resection is achievable while preserving functional and cosmetic integrity, upfront surgical resection followed by adjuvant chemoradiotherapy is recommended. 26 , 27 , 28 , 29 Notably, children are characterized by low body weight and a small total blood volume. The systemic blood volume in children is about 8% of body weight, while in adults it is about 6%. 30 Therefore, intraoperative blood loss has a greater impact on the circulatory system in children. Moreover, the liver and kidney functions of children, especially newborns and infants, are not fully developed, leading to slower metabolism and clearance of anesthetic drugs, which increases the risk of anesthesia compared to that in adults. 31 , 32 Therefore, leveraging AI technology and digital healthcare to accurately assess the location of nasal skull base tumors, their blood supply, and the involvement of the surrounding tissue preoperatively is critical for developing individualized surgical plans, evaluating surgical risks, predicting disease prognosis, and formulating comprehensive healthcare management strategies. POTENTIAL APPLICATIONS OF AI AND DIGITAL MEDICINE IN PEDIATRIC NASAL SKULL BASE TUMOR DIAGNOSIS Application of AI to diagnostic imaging Computed tomography (CT) and magnetic resonance imaging (MRI) have become routine adjuncts for the diagnosis and treatment of pediatric nasal skull base tumors. CT effectively displays the extent of bone destruction caused by the tumor, as well as lesion location and scope. MRI, with its high resolution for soft tissue, better demonstrates tumor involvement in both internal and surrounding soft tissues. 33 With the continuous development of machine learning and deep learning in AI, the application of digital medicine to imaging has been promoted. 34 Spectral CT is characterized by low radiation dose, high spatial resolution, good imaging contrast, and fewer artifacts. 35 However, if only photon‐counting spectral CT is used as an analysis method, the noise in the projection will mask most of the image details and features, resulting in an image quality that cannot be interpreted in clinical practice. Wu et al. 36 utilized deep learning algorithms to innovate on traditional techniques and build the ULTRA (U‐net with Lp p‐norm, Total variation, Residual learning, and Anisotropic adaptation, ULTRA) network. This network can reduce image noise while preserving image details, significantly improving image quality with relatively low computational costs, resulting in high‐quality spectral CT imaging. Deep learning image reconstruction (DLIR), a novel image reconstruction method, has been applied to low‐dose pediatric sinus CT images. It achieves excellent image quality by maintaining high resolution, improving image texture, and reducing image distortion. 37 In recent years, there has been a surge in the popularity of three‐dimensional (3D) reconstruction for medical imaging. This technique processes and segments digital imaging data (CT and MRI) using software such as Mimics or 3D Slice to extract target anatomical structures (e.g., bones and organs), followed by 3D modeling using computer‐aided design software like Blender or Materialize. 38 With 3D reconstruction, doctors can more accurately assess tumor size, shape, and location, as well as its relationship with the surrounding tissue, helping to improve treatment plans. Currently, 3D printing has been widely used in medicine for producing anatomical models, surgical guides, implants, and bioprinting. 39 Given the special anatomical location of the nasal skull base and the complex adjoining structures around it, the 3D reconstruction technique can precisely locate the tumor and its involved or adjacent vessels and nerves. 40 Preoperatively, this technology allows surgeons to obtain a patient‐specific anatomical model, which is particularly valuable for highly vascularized nasal skull (e.g., nasopharyngeal angiofibroma, ossifying fibroma, and aneurysmal bone cysts) and malignant tumors involving complex anatomical structures (e.g., RMS involving the pterygopalatine fossa or lymphomas compressing optic nerves or encroaching on the intracranial area). 41 , 42 , 43 , 44 One study found that 3D‐printed models serve as an effective tool for doctor‐patient communication in preoperative consultations for pediatric endoscopic nasal skull base surgery, helping patients and their families better understand the extent of the lesion before surgery, visualize the relationship between the lesion and critical anatomical structures such as the orbit, brain, and neurovascular structures, and assist in developing surgical planning and complication assessment. 45 Zahid et al. 46 successfully created and applied a 3D‐printed biological model of JNA tailored to individual patient characteristics. The surgical team utilized this model for preoperative and intraoperative tumor visualization to plan the optimal surgical approach, ultimately achieving high‐precision tumor resection and minimizing adverse outcomes in high‐bleeding‐risk procedures. Convolutional neural network (CNN), a representative deep learning algorithm, is considered a leading technology in digital image analysis, demonstrating exceptional performance. 47 By automating and standardizing the classification, segmentation, and diagnosis of medical images, it can greatly assist the development and improvement of clinical medicine. 48 However, the role of CNN goes beyond this. Pediatric nasal skull base tumors present challenges in early diagnosis. Craniopharyngioma is the most commonly diagnosed benign tumor in the sellar and suprasellar regions among pediatric patients. 49 Castiglioni et al. 50 developed a convolutional deep learning algorithm for pediatric craniopharyngioma, which can assist in radiological diagnosis and provide a promising new tool for the identification and diagnosis of this type of tumor. Malignancies of the nasal cavity and paranasal sinuses are relatively rare in head and neck tumors. 51 Squamous cell carcinoma (SCC) is the most common type of sinonasal malignancies, while other major pathological types include adenoid cystic carcinoma (ACC), olfactory neuroblastoma (ONB), sinonasal undifferentiated carcinoma, and sinus melanoma. 52 , 53 Because SCC and non‐SCC differ significantly in terms of invasiveness, treatment options, and survival rates, early detection and differentiation of SCC and non‐SCC tumors are crucial for guiding clinical decision‐making and assessing prognosis. 54 , 55 MRI plays a key role in the diagnosis of sinonasal tumors due to its excellent soft tissue resolution. 56 Recently, Wang et al. 57 recruited 465 patients with sinonasal malignant tumors (age: 5–91 years) and developed a CNN‐based deep learning model (ResNet101 network) using MRI data to differentiate SCC, ACC, and ONB. This model can assist radiologists in making more accurate diagnoses, especially for less experienced junior radiologists. The study by Ramkumar et al. 58 demonstrated that a machine learning model based on MRI texture analysis achieved an accuracy of 89.1% in distinguishing between sinonasal SCC and inverted papilloma, showing comparable performance to the manual assessments by neuroradiologists (P = 0.0004). The development of a 3D‐CNN‐based automatic imaging reconstruction system (Cerebral Doc) efficiently reconstructs head and neck computed tomography angiography (CTA) images for detailed blood vessel observation. 59 Combined with medical 3D printing technology and computer‐aided design (CAD) software, it creates a 3D model that clearly shows the spatial relationships among the nasal skull base structure, tumors, and key blood vessels. These individualized digital medicine and AI technologies have achieved breakthroughs from 2D imaging to 3D models, significantly enhancing surgical safety assessment for pediatric skull base procedures. They help guide surgeons to maximize tumor removal to reduce recurrence while avoiding damage to blood vessels and nerves, thus lowering the incidence of intraoperative bleeding and postoperative complications. Application of AI in the pathologic diagnosis Pathological examination is the gold standard for tumor diagnosis. 60 In recent years, AI has advanced digital pathology in oncology by mitigating the subjectivity inherent in visual assessment. Whole slide imaging technology can generate digital images by scanning glass slides, which has advanced the development of digital pathology. 61 AI‐based digital pathology technologies have been widely applied for tumor diagnosis, subtyping, grading, staging, and prognosis. 62 On the one hand, digitized histopathology images enable rapid AI‐driven feature recognition, improving diagnostic efficiency and saving repetitive manpower for large case volumes or serial sections. 63 On the other hand, AI demonstrates excellent recognition of tiny lesions or micrometastases, minimizing missed diagnoses. A study showed that AI‐based rapid feature recognition on histopathological digital images is more effective than traditional reading methods for detecting cancer tissue. 64 RMS is classified into four histological subtypes: embryonal, alveolar, mixed, and pleomorphic, with embryonal RMS (eRMS) being the most common histological subtype in children. 65 , 66 , 67 , 68 This subtype mostly occurs in the head and neck region, mainly affecting parameningeal sites such as the nasal cavity and paranasal sinuses. 69 , 70 Zhang et al. 71 developed a CNN model that accurately classifies RMS histological subtypes on pathological slides. Utilizing transfer learning, they further stratified 60 eRMS patients into low‐ and high‐risk groups, demonstrating the potential of pathological slide‐based risk stratification. Such models can enhance pathological assessment efficiency and assist clinicians in more accurately evaluating disease progression risks, thereby formulating more reasonable treatment planning. PathChat is a multimodal generative AI assistant applied in pathology that is capable of understanding and processing both visual and language inputs. It provides more precise and desirable responses to various pathological questions. When combined with a clinical context, PathChat achieves an accuracy of up to 89.5% in correctly identifying diseases from biopsy slides. 72 Using this tool, it is possible to automatically and rapidly calculate the predicted cancer proliferation rate during slide scanning, which helps to assess the aggressiveness of pediatric nasal skull base malignant tumors and the prognosis of patients. Banerjee et al. 73 proposed a deep learning‐based computer‐aided diagnosis system that utilizes transfer learning with fused multiparametric MRI to classify histopathological subtypes of RMS. The trained model achieved 85% accuracy in this subtype. 73 Stimulated Raman histology (SRH) is a rapid, label‐free, high‐resolution laser imaging method. By leveraging the intrinsic vibrational properties of lipids, proteins, and nucleic acids to generate image contrast, SRH facilitates direct pathological imaging of unprocessed fresh tissue. This obviates the time‐consuming steps like frozen sectioning, staining, and complex sample preparation, greatly improving the efficiency of intraoperative assessments. 74 , 75 For skull base tumors—whether benign (e.g., meningiomas, pituitary adenomas, and schwannomas) or malignant (e.g., chordomas and sinonasal carcinomas)—the rapid and accurate intraoperative evaluation of histopathological features and tumor infiltration extent is paramount for optimizing surgical strategies and improving patient prognoses. Leveraging SRH technology, one research team has developed an AI model capable of highly efficient pathological evaluation of skull base specimens. Specifically, these models effectively detect microscopic tumor infiltration within SRH images and precisely delineate the tumor‐normal tissue interface, achieving robust margin assessment during meningioma resection. 76 While AI‐driven pathology demonstrates significant potential for rapid intraoperative and postoperative assessments, its clinical application in pediatric nasal skull base tumors remains limited. POTENTIAL APPLICATION OF AI AND DIGITAL MEDICINE IN PEDIATRIC NASAL SKULL BASE TUMOR TREATMENT Surgical treatment Intraoperative real‐time 3D navigation imaging has been widely used in nasal endoscopy and has effectively reduced intraoperative blood loss and improved surgical safety. 77 A study compared the Stryker navigation system (Stryker Neuronavigation ENT 2.0 Software) in adult and pediatric nasal endoscopic surgery. Results showed no difference in calibration accuracy between adults and children, and the incidence of complications in children was zero, indicating the system is well‐suited for pediatric use. 78 A new augmented reality (AR) navigation system for nasal endoscopy and skull base surgery provides rhinologists with more intuitive and detailed imaging information, helping to reduce surgery time and improve surgical success in complex nasal and skull base surgeries. 79 , 80 A wearable AR navigation system based on Microsoft HoloLens, which allows remote guidance for surgery, has great potential to improve surgical care for patients in remote areas and reduce healthcare disparities. 81 In addition, this technology can be combined with surgical robots to achieve true “remote surgery.” At present, robot‐assisted surgery has gradually become integrated into clinical practice. Compared to traditional surgical methods, it has demonstrated significant advantages in pediatric tumor surgeries. 82 The surgical robot uses an imaging system to provide clinicians with high‐definition, realistic 3D images. This helps define tumor margins and enables precise, real‐time positioning during surgery. Long, intense operations often push clinicians beyond their physiological limits. The robotic arm helps by reducing natural hand tremor, which in turn reduces additional surgical damage. Carrau et al. 83 combined a surgical robot with a nasal endoscopic approach to achieve excellent results in the surgical resection of malignant tumors with extensive involvement of the skull base and effectively avoided complications such as cerebrospinal fluid leakage. Zalzal and Turner 84 shared their experience in performing surgery for JNA using an endoscopic nasal approach and robot‐assisted transmaxillary resection of the pterygopalatine fossa and infratemporal fossa. Postoperative follow‐up of the patient showed excellent prognosis and cosmetic result. Compared with traditional endoscopic nasal surgery, the robot‐assisted skull base approach has significant advantages in optical imaging quality, surgical access, ergonomics, and the facilitation of bimanual operation Complete tumor removal is an important indicator for evaluating treatment outcomes. However, for large defects involving the skull base or large tumors affecting the craniofacial region, the challenge for clinicians lies in how to repair the area while removing the lesion. 3D bioprinting technology offers personalized implants tailored to the patient, maximizing the reconstruction of the tissue structure. 85 However, at the current stage, most of these technologies have been primarily validated in adult cohorts, rigid models, or cadaver experiments; their extrapolation to pediatric populations necessitates rigorous clinical validation. Drug therapy In addition to surgery, malignant tumors of the nasal skull base often require chemotherapy as an adjunct treatment. Traditional chemotherapy drugs, due to their low specificity, can easily cause systemic side effects such as nausea, vomiting, neutropenia, and weakened immune function, which severely impact the quality of life of pediatric patients. 86 A study employed a machine learning framework utilizing a gradient boosting regressor to predict hematologic toxicity induced by the chemotherapy drug ifosfamide in patients with RMS. This model accurately forecasts neutrophil and platelet levels in new patients. 87 Targeted cancer therapy is a cornerstone of modern precision medicine. By selectively targeting the unique genetic mutations, proteins, or pathways of tumor cells, it enables the precise attack on malignancies while sparing healthy tissues. AI helps identify cancer‐related pathways and mutations by integrating large‐scale datasets across genomics, proteomics, and other omics disciplines. This enables precise pinpointing of specific proteins, genes, or pathways that drive cancer development and progression. 88 , 89 , 90 In addition to identifying novel therapeutic targets, AI has demonstrated profound potential in the development and clinical translation of anti‐cancer drugs. 91 As traditional drug discovery is costly and slow, drug repurposing—finding new clinical indications for approved therapeutics—offers a faster, more efficient alternative. Because these drugs already have known safety profiles, they can bypass phase I trials and proceed directly to phase II to evaluate efficacy for new indications. This strategy significantly reduces research and development risks and costs, offering immense translational value. 92 , 93 AI holds great potential in this area, as it facilitates the repurposing of existing anti‐cancer drugs for new therapeutic applications. 94 , 95 Baek et al. 96 used a comprehensive drug response prediction model to reveal that NSC207895, vorinostat, and belinostat exhibit selective anti‐RMS activity, highlighting their potential as promising novel therapeutics for RMS. Robotic drug delivery is a cutting‐edge medical application that utilizes robotics to improve the precision and efficiency of drug delivery. 97 Common drug‐carrying robots include nanorobots and microrobots, which can directly penetrate the biological barriers and deliver drugs to the tumor sites in a targeted manner through manipulation of magnetic fields, acoustic waves, and biology, reducing damage to healthy tissue and the occurrence of side effects. 97 , 98 , 99 , 100 Although the application of AI in pharmacotherapy is becoming increasingly widespread, reports on its use in pediatric oncology remain scarce, indicating substantial application prospects. POTENTIAL APPLICATION OF AI AND DIGITAL MEDICINE IN PEDIATRIC NASAL SKULL BASE TUMOR WHOLE‐PROCESS MEDICAL MANAGEMENT Pediatric patients have a longer expected lifespan, making a good prognosis especially important. The whole‐process medical management model continuously records medical information, including individualized diagnosis, treatment, prognosis, and follow‐up. AI and digital medical re‐diagnosis have already been used, but individualized post‐operative assessment, disease tracking, and follow‐up are more critical. This model better supports resource sharing and remote diagnosis and treatment. Developing an AI medical follow‐up system is a key part of this whole‐process management. Epic MyChart is a patient‐oriented electronic health record (EHR) system that automatically reminds patients of follow‐up appointments and treatment plans. Patients can also easily view their health information and discuss it with healthcare providers. AI can automatically assess the prognosis and design personalized follow‐up plans. The system also provides real‐time remote monitoring, data analysis, trend reports, risk warnings, and helps doctors adjust treatment plans promptly. 101 ChatGPT is a large‐scale language model developed by OpenAI. Based on the GPT‐4 architecture, it is capable of understanding and generating natural language. ChatGPT can help patients with health management, such as getting information about diseases and medical queries. 102 , 103 Ye et al. 104 found that ChatGPT can accurately answer patient questions about allergic rhinitis and chronic rhinosinusitis. Since ChatGPT summarizes disease information from various sources, including etiological studies, surgical treatments, and medication options, it can guide patients on medication use and improve their lifestyle habits. The software can also summarize conversations with patients to generate medical data for doctors and generate personalized medical resources for ongoing follow‐up. Therefore, ChatGPT is a very promising generative AI tool. 105 Long‐term follow‐up for pediatric tumors requires continuous care. ChatGPT can help in the postoperative management of children with nasal skull base tumors by answering questions and recording data, enabling an individualized whole‐process medical management model (Figure 1). A newly developed wearable ultrasound device provides continuous, high‐quality images of deep tissue with real‐time patient monitoring. 106 Clinicians use it to monitor postoperative recovery. Outside hospitals, these devices can be taken to remote areas as diagnostic and monitoring tools, making medical imaging more accessible and affordable for low‐ and middle‐income populations. 106 We envision using this device in children with nasal skull base tumors to overcome the challenge of long‐term follow‐up data collection. In addition, the ENLIGHT‐DeepPT model has been developed to predict patient outcomes. The DeepPT model uses deep learning framework to predict whole‐genome tumor mRNA expression from pathology slides, and the ENLIGHT method uses these predictions to assess patients’ responses to targeted therapies and immunotherapies. This model has shown promising applications across cancer types, providing an effective prognostic tool for a broad range of tumor patients. 107 Artificial Intelligence (AI) and digital medicine in the whole‐process medical management model. Constructing a whole‐process AI management model for pediatric nasal skull base tumors is challenging, but adult models provide useful references in data collection, triage, and follow‐up. Existing adult models can build a large training cohort from a single institution's EHR. However, due to the extremely low incidence of pediatric nasal skull base tumors, we need a cross‐institutional, multi‐center, multi‐modal database. Beyond standard imaging and pathological data, this database must include longitudinal data on a child's growth and development (craniofacial skeletal development baselines) and tumor‐specific biomarkers (e.g., FOXO1 in RMS and CTNNB1 in craniopharyngioma). 108 , 109 This comprehensive database is essential for providing AI models with relevant and biologically targeted pediatric inputs. Adult AI triage systems are often used for emergency prioritization and high‐risk screening. 110 , 111 In children, urgency depends not only on narrow nasal and skull base anatomy but also on disease biology. For instance, JNA is highly vascular and prone to sudden and massive hemorrhage, while RMS rapidly invades locally, causing airway obstruction or intracranial extension. 112 We can adopt adult risk stratification algorithms to develop early warning models for pediatric emergencies. By analyzing initial imaging features, these models can help clinicians assess surgical timing and urgency before irreversible damage occurs. Postoperative longitudinal follow‐up is a core component of the whole‐process management and represents the biggest differences between children and adults. Adult follow‐up models assume static anatomy, but a child's craniofacial skeleton and sinuses continue growing for years postoperatively. Therefore, when adapting adult recurrence monitoring models, we must integrate algorithms that track these dynamic changes. Future pediatric monitoring AI must be highly sensitive to detect early occult recurrence while remaining specific enough to distinguish true recurrence from normal growth changes, avoiding unnecessary biopsies or excessive radiation. LIMITATIONS AND CHALLENGES There is no doubt that technological advances have contributed to medical advances, yet there are limitations to the clinical use of AI and digital medicine. First, AI technology requires a lot of investment, including hardware facilities, software development, and maintenance costs. Second, the performance of AI systems is highly dependent on digitized healthcare data. If the data is inaccurate or incomplete, then the diagnosis and decision‐making provided by the AI can be seriously inaccurate or even misjudged. 113 It is also a huge challenge to effectively protect patient privacy, and patient medical data breaches can lead to serious consequences. Moreover, if errors in AI autonomous decision‐making lead to misdiagnosis or improper treatment, determining liability will be a complex issue. The current legal and regulatory frameworks have not yet fully addressed these emerging medical challenges. 113 Currently, most AI prediction models achieve high precision and robust performance by integrating multimodal features such as clinical, radiological, and pathological data and undergoing deep training on large‐scale, standardized datasets. 114 , 115 However, in pediatric nasal skull base tumors, the low disease incidence and resulting scarcity of clinical samples pose significant challenges, providing insufficient data to construct robust deep learning algorithms. Unlike adults, the pediatric nasal skull base structures undergo continuous dynamic development, characterized by processes such as paranasal sinus maturation and sphenoid sinus pneumatization. 116 , 117 , 118 Furthermore, the pediatric skeleton features unossified cartilaginous growth plates, which manifest as “fissures” or “radiolucent zones” on X‐rays or CT imaging. 119 Consequently, AI models trained predominantly on adult datasets often fail to recognize these normal pediatric variations, frequently misinterpreting physiological growth patterns as pathological lesions. Due to these differences between children and adults, existing models trained on adult data cannot be directly applied to pediatric patients. 120 Although advanced technologies, including SRH, surgical robotics, and large foundation models, have achieved breakthroughs in adult oncology, their direct extrapolation to pediatric nasal and skull base tumors still encounters substantial technical and clinical translational barriers. Consequently, clarifying which aspects of existing technologies can be directly transferred and which necessitate targeted reconfiguration is key to objectively assessing system transferability and propelling their successful translation into pediatric clinical practice. The algorithmic logic of radiomics feature extraction methods for adults can be directly transferred. However, pediatric patients undergo a dynamic developmental phase of the craniofacial skeleton and paranasal sinuses. Additionally, children often require sedation or anesthesia during prolonged, high‐resolution MRI or CT scans due to limited compliance. Consequently, future imaging‐assisted models cannot rely simply on adult steady‐state data; instead, strategies should be adjusted. On one hand, it is imperative to establish dynamic baseline databases tailored to age‐specific pediatric characteristics. On the other hand, techniques such as DLIR can be introduced to minimize scan time and radiation dose while enabling the extraction of stable features from images that may contain motion artifacts. 37 Although the optical hardware of digital pathology techniques, such as SRH, is directly applicable to pediatric tissues, 76 the principal barrier to translating existing models into pediatric practice lies in the significant distribution mismatch between the training data and the target population. Currently, mature models are mostly trained on high‐incidence adult malignancies, such as gliomas and breast cancer. However, the histological subtypes and microscopic cellular morphology of pediatric nasal and skull base tumors, such as RMS and JNA, differ markedly from those of prevalent adult tumors. Due to the lack of targeted training, the direct diagnostic efficacy of current adult‐derived models is substantially constrained when applied to pediatric cohorts. For digital pathology analysis, classical image recognition networks (e.g., ResNet) combined with transfer learning demonstrate strong application potential. By preserving the pre‐trained networks’ capacity to recognize general histological features, researchers need only conduct localized fine‐tuning using limited pediatric‐specific datasets. 57 Currently, this paradigm represents a practical solution to overcome the challenge of limited sample sizes in pediatrics. AR and surgical robotics have demonstrated immense clinical value in complex adult skull base surgeries, 79 , 80 , 81 , 83 , 97 , 107 and their underlying spatial localization algorithms and three‐dimensional visualization techniques are transferable to pediatric applications. However, the genuine limitations lie in the dimensional compatibility. Pediatric endoscopic endonasal surgical corridors are narrower, and structures such as the sphenoid sinus may not have achieved complete pneumatization. Direct use of adult‐designed robotic arms or conventional surgical instruments may increase the risk of iatrogenic injury to adjacent neurovascular structures. Therefore, future translation requires not only the miniaturization of surgical instruments but also AR navigation systems adapted to the developing pediatric skull base anatomy for more precise intraoperative dynamic registration. At the therapeutic decision‐making level, prognostic evaluation models based on large‐scale adult cohorts are difficult to directly apply to pediatric patients. Given that pediatric malignancies, such as RMS, have a unique genomic mutation spectrum, and their pharmacokinetic characteristics differ from those of adults, AI models for predicting chemotherapy toxicity or targeted therapy responses must be retrained using pediatric‐specific multi‐omics and pharmacokinetic data. In contrast, EHR systems based on natural language processing and general large language models face relatively lower clinical translation barriers in terms of doctor‐patient communication and follow‐up management. 101 , 103 These applications require only the adaptation of specialized knowledge bases to align with pediatric care guidelines and parental health education, enabling rapid promotion and implementation. The conventional single‐center internal validation model employed in adult studies is highly challenging to implement for pediatric nasal and skull base tumors. Due to the low incidence of these tumors, relying solely on single‐center data can easily lead to model overfitting. Furthermore, the tolerance for error in pediatric clinical decision‐making is extremely low, and regulatory agencies impose stricter requirements on the transparency of assistive systems when applied to pediatric populations. This means that future system designs must prioritize the interpretability of results to provide compelling clinical references. However, we have expectations for the clinical application of AI and digital medicine for pediatric nasal skull base tumors, and its great potential for early diagnosis and precision medicine should not be overlooked, 121 as it is becoming more popular. Hopefully, AI and digital medicine will profoundly change the way we treat pediatric patients with nasal skull base tumors. Despite significant advances in the past decade, there is still an urgent need to improve the whole‐process medical management model of early diagnosis, risk prediction, and follow‐up assessment of pediatric patients with nasal skull base tumors. CONFLICT OF INTEREST The authors declare no conflict of interest. ACKNOWLEDGMENTS This work was supported by Capital's Funds for Health Improvement and Research (2024‐2‐2098), Respiratory Research Project of National Clinical Research Center for Respiratory Diseases (HXZX‐202109), Capital's Funds for Health Improvement and Research (2024‐1‐2093), Beijing Natural Science Foundation (7242052), Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University (CCMU2023ZKYXY001). Contributor Information Wentong Ge, Email: gwt@bch.com.cn. Yang Han, Email: hany_ent@126.com. REFERENCES